| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Revenues | 0 | 0 | ||
| Selling, general and administrative | 115,099 | 13,614 | ||
| Total operating expenses | 115,099 | 13,614 | ||
| Loss from operations | -115,099 | -13,614 | ||
| Interest expense - related parties | 2,710 | 1,948 | ||
| Total other expenses | 2,710 | 1,948 | ||
| Loss before income tax expense | -117,809 | -15,562 | ||
| Income tax expense | 0 | 0 | ||
| Net loss | -117,809 | -15,562 | ||
| Basic and diluted loss per share of common stock | 0 | 0 | ||
| Weighted average number of shares of common stock outstanding | 60,042,000 | 60,042,000 | ||
ACRO BIOMEDICAL CO., LTD. (ACBM)
ACRO BIOMEDICAL CO., LTD. (ACBM)